ENDOCEUTICS
The computed 12-month bankruptcy probability of ENDOCEUTICS is 2.0% (moderate). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 7 yrs |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 14-08-2025 | 2025-00381875 |
| 31-12-2023 | volledig | 18-07-2024 | 2024-00261210 |
| 31-12-2022 | volledig | 02-05-2023 | 2023-00080499 |
| 31-12-2021 | volledig | 08-08-2022 | 2022-20275147 |
| 31-12-2020 | volledig | 29-07-2021 | 2021-44900135 |
| 31-12-2019 | volledig | 25-06-2020 | 2020-20100417 |
| NACE primary | Wholesale trade(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 06-12-2018 |
| Status | Active |
| Postal code | 1040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21805E0283/00C000 | Brussels | 3,919 m² | 1 · 1,800 m² | 58.6 m · 15 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
01-02-2024 Change in the board of directors
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "RENS ACCOUNTANTS",
"address": "2800 Mechelen, Schali\u00EBnhoevedreef 20 E",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Fr\u00E9d\u00E9ric de GRAVE",
"firm_city": null,
"firm_name": "DEPUYT, RAES \u0026 de GRAVE",
"office_city": "Molenbeek-Saint-Jean",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-01",
"filing_date": "2024-01-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-12-26",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0715.565.040",
"name_full": "ENDOCEUTICS",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "F. de GRAVE",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Exp\u00E9dition",
"2 procurations",
"2 d\u00E9cisions du Conseil d\u2019administration du 14/12/2023",
"historique",
"coordination"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | ENDOCEUTICS |